Dca Vantage, Model 5075
Assay, Glycosylated Hemoglobin. 510(k) K071466, from Siemens Medical Solutions Diagnostics (Norowood, MA). Product code LCP, class 2.
As of Nov 19, 2026, K071466 is an FDA 510(k) held by Siemens Medical Solutions Diagnostics, substantially equivalent on Oct 9, 2007 after 133 days, with 1 recall tied to it in FDA's recall database.
- Review time: 133 days
- Recalls: 1
- Cited as a predicate by: 5 devices
The DCA Vantage™ is a semi-automated, benchtop system. It is designed to quantitatively measure the percent Hemoglobin A1c in blood and low concentrations of albumin in urine (microalbuminuria), creatinine in urine, and the albumin/creatinine ratio in urine. The measurement of hemoglobin A1c concentration is recommended for monitoring the long-term glycemic control of persons with diabetes.
- cobas HbA1c Test, cobas b 101 systemK163633 · Roche Diagnostics Operations · Jul 28, 2017
- URight Hemoglobin A1c system, FORA A1c SystemK142664 · Taidoc Technology Corporation · Jan 29, 2016
- A1C Gear SystemK130014 · Sakae Corporation · Apr 4, 2014
- S- Test Hemoglobin Alc (HBA1C), Model RC0023K091711 · Alfa Wassermann Diagnostic Technologies, Inc. · Dec 11, 2009
- Clover A1C/Glycosylated Hemoglobin Monitor & Blood Glucose Monitor, Model IGM-0023K082275 · Infopia Co, Ltd. · Jan 14, 2010
| Started | Recall | Status |
|---|---|---|
| Jun 30, 2020 | Z-2747-2020If DCA Vantage Analyzer is configured to run Code 39 with check digit, the scanner is not confirming the integrity of read barcode data using the check digit. Also, if DCA Vantage Analyzer is configured to run Code 39… | Terminated |
- Q-Pad Test SystemK231465 · Qurasense · Dec 6, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- May 29, 2007
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7470
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files